-
Mashup Score: 108
A sprawling new study found that women are less likely to die or have to return to the hospital if they are treated by a female doctor compared to a male doctor. NBC’s Emilie Ikeda reports and Dr. Natalie Azar joins TODAY to break down the report.
Source: www.today.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 108
A sprawling new study found that women are less likely to die or have to return to the hospital if they are treated by a female doctor compared to a male doctor. NBC’s Emilie Ikeda reports and Dr. Natalie Azar joins TODAY to break down the report.
Source: www.today.comCategories: General Medicine News, CardiologistsTweet-
Thanks to @TODAYshow for having me on this morning to talk about the importance of female representation in medicine! 🫀👩⚕️‼️ cc: @UCSFSurgery @UCSFCTSurgery @UCSFHospitals https://t.co/Zd0u12DLh8
-
-
Mashup Score: 105
A sprawling new study found that women are less likely to die or have to return to the hospital if they are treated by a female doctor compared to a male doctor. NBC’s Emilie Ikeda reports and Dr. Natalie Azar joins TODAY to break down the report.
Source: www.today.comCategories: General Medicine News, CardiologistsTweet-
Thanks to @TODAYshow for having me on this morning to talk about the importance of female representation in medicine! 🫀👩⚕️‼️ cc: @UCSFSurgery @UCSFCTSurgery @UCSFHospitals https://t.co/Zd0u12DLh8
-
-
Mashup Score: 105
A sprawling new study found that women are less likely to die or have to return to the hospital if they are treated by a female doctor compared to a male doctor. NBC’s Emilie Ikeda reports and Dr. Natalie Azar joins TODAY to break down the report.
Source: www.today.comCategories: General Medicine News, CardiologistsTweet-
Thanks to @TODAYshow for having me on this morning to talk about the importance of female representation in medicine! 🫀👩⚕️‼️ cc: @UCSFSurgery @UCSFCTSurgery @UCSFHospitals https://t.co/Zd0u12DLh8
-
-
Mashup Score: 29Improving Upon the Ice Ages: Is SherpaPak the Solution? - 20 day(s) ago
Correspondence to: Amy G. Fiedler, MD, Department of Surgery, Division of Cardiothoracic Surgery, University of California, San Francisco, 513 Parnassus Ave, Medical Sciences Bldg, Ste 309, San Francisco, CA 94143. Email Department of Surgery, Division of Cardiothoracic Surgery, University of California, San Francisco. For Sources of Funding and Disclosures, see page xxx. The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. Correspondence
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Had a lot of fun writing this editorial for @CircAHA regarding the enormous impact @ParagonixSherpa has on our 🫀transplant population https://t.co/xnn9AtoVjn
-
-
Mashup Score: 33Is It Time to Stop Living in a HeartMate II World? - 6 month(s) ago
Despite improving outcomes with modern pump technology, LVAD utilization for patients with end-stage heart failure has declined significantly in the preceding half decade. Here, we examine this trend, noting an inherent contradiction in declining utilization of an improving therapeutic option. We propose a series of provocative questions as a “call to action” for the field of advanced heart failure to consider both scientifically and clinically, focusing on our evaluation parameters for LVAD candidacy, our approach to dichotomous LVAD versus transplant decisions, and our current management paradigms.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet-
Check out our editorial @TheJHLT with some hot 🔥takes on contemporary management of LVAD patients! cc: @JasonKatzMD @LiviuKlein https://t.co/Mk2i4PV9VL
-
-
Mashup Score: 33Is It Time to Stop Living in a HeartMate II World? - 6 month(s) ago
Despite improving outcomes with modern pump technology, LVAD utilization for patients with end-stage heart failure has declined significantly in the preceding half decade. Here, we examine this trend, noting an inherent contradiction in declining utilization of an improving therapeutic option. We propose a series of provocative questions as a “call to action” for the field of advanced heart failure to consider both scientifically and clinically, focusing on our evaluation parameters for LVAD candidacy, our approach to dichotomous LVAD versus transplant decisions, and our current management paradigms.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet-
Check out our editorial @TheJHLT with some hot 🔥takes on contemporary management of LVAD patients! cc: @JasonKatzMD @LiviuKlein https://t.co/Mk2i4PV9VL
-
-
Mashup Score: 1Is It Time to Stop Living in a HeartMate II World? - 9 month(s) ago
Despite improving outcomes with modern pump technology, LVAD utilization for patients with end-stage heart failure has declined significantly in the preceding half decade. Here, we examine this trend, noting an inherent contradiction in declining utilization of an improving therapeutic option. We propose a series of provocative questions as a “call to action” for the field of advanced heart failure to consider both scientifically and clinically, focusing on our evaluation parameters for LVAD candidacy, our approach to dichotomous LVAD versus transplant decisions, and our current management paradigms.
Source: www.jhltonline.orgCategories: Cardiologists, Latest HeadlinesTweet-
Check out our editorial @TheJHLT with some hot 🔥takes on contemporary management of LVAD patients! cc: @JasonKatzMD @LiviuKlein https://t.co/Mk2i4PV9VL
-
-
Mashup Score: 3Hearts in Sonoma- UCSF Update on Heart Failure Therapies 2023 - 10 month(s) ago
UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health. You are hereHome > Hearts in Sonoma- UCSF Update on Heart Failure Therapies 2023 …
Source: UCSF Virtual CE PortalCategories: Cardiologists, Latest HeadlinesTweet-
RT @LiviuKlein: Amazing conference, great topics and speakers. Early bird registration until 8/1. https://t.co/23wpVbsjPJ @AG_EM33 @Fie…
-
-
Mashup Score: 3NightLife: Says Who? Vol. 3 Gender - 10 month(s) ago
What’s gender got to do with it? More than you think. Hear how scientists defy gender barriers to create change.
Source: California Academy of SciencesCategories: Cardiologists, Latest HeadlinesTweet-
🔥⭐️ SO EXCITED to be a panelist @calacademy #nightlife Thurs 6/29 doors @ 6. Join us for a conversation around gender and women in STEM! cc: @UCSFHospitals @UCSFSurgery @UCSFCTSurgery https://t.co/sCXe6uJcGM
-
Thanks to @TODAYshow for having me on this morning to talk about the importance of female representation in medicine! 🫀👩⚕️‼️ cc: @UCSFSurgery @UCSFCTSurgery @UCSFHospitals https://t.co/Zd0u12DLh8